Article

CURE Features First-Ever Social Media Takeover

CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group’s flagship product, CURE® magazine, the nation’s leading consumer digital and print media enterprise focusing on patients with cancer, is kicking off its first-ever social media takeover today, when Moving Mountains for Multiple Myeloma climber April Cooper controls the @curetoday Instagram feed.

“We are excited to launch the first-ever social media takeover for CURE®, said Michael J. Hennessy Jr, president of MJH Associates, parent company of CURE Media Group. This takeover will be a behind-the-scenes look, as she’ll be talking about her experience during her mother’s Multiple Myeloma journey, and sharing her climb through photos, videos and Instagram stories.”

Cooper, who is a resident of Dallas, Texas, will be climbing Mount Democrat in Colorado as part of the Multiple Myeloma Research Foundation’s Peak Weekend program and a Moving Mountains for Multiple Myeloma (MM4MM) initiative.

Follow Cooper on her weekend journey as she hikes the Rocky Mountains at 14,158 feet above sea level to honor her mother and to help raise awareness for multiple myeloma.

Follow CURE® on Instagram @curetoday, or follow #CURE or #MM4MM.

Related Videos
Dr. Mikhael in an interview with CURE
Dr. Ajai Chari in an in interview with CURE
An image of Dr. Patel in an interview with CURE discussing healthy lifestyles in myeloma
Dr. Munshi in an interview with CURE
Dr. Dikran Kazandjian during an interview with CURE
Related Content
Image of red blood cells.
November 18th 2024

Blenrep-Based Combo Provides Survival Benefit in Relapsed/Refractory Multiple Myeloma

Darlene Dobkowski, MA
Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be presented at an upcoming conference.
Top Headlines on CAR-T Cell Therapy
December 4th 2023

Top Headlines on CAR-T Cell Therapy

Alex Biese Brielle Benyon
From FDA concerns to a potential new drug, CAR-T cell therapies were dominating oncology headlines last week.
Image of a myeloma cell with a magnifying glass over it.
November 11th 2024

FDA Receives Application Seeking Approval of Darzalex Faspro in Smoldering Myeloma

Darlene Dobkowski, MA
If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.
Health Care Worker Discusses Cancer Diagnosis and Vaccine Experience While on the Frontlines of the COVID-19 Pandemic
January 13th 2022

Health Care Worker Discusses Cancer Diagnosis and Vaccine Experience While on the Frontlines of the COVID-19 Pandemic

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a physician assistant recalls his experience as a frontline health care worker during the COVID-19 pandemic and what it was like to get diagnosed with multiple myeloma during such a chaotic time.
Image of three icons related to multiple myeloma.
November 5th 2024

Carvykti Effective for R/R Multiple Myeloma in Real-World Setting

Alex Biese
The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.
image of breast cancer cells.
October 25th 2024

Jenna Fischer Shares Breast Cancer Details, Los Angeles Dodgers Broadcaster in Remission and More

Alex Biese Ashley Chan
From “The Office” star opening up in a new interview to Charley Steiner revealing his multiple myeloma journey, here is this week’s cancer news.